Anandamide: an endogenous activator of the vanilloid receptor

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.21, Iss.4, 2000-04, pp. : 134-134

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pulmonary actions of anandamide, an endogenous cannabinoid receptor agonist, in guinea pigs

By Stengel P.W. Rippy M.K. Cockerham S.L. Devane W.A. Silbaugh S.A.

European Journal of Pharmacology, Vol. 355, Iss. 1, 1998-08 ,pp. : 57-66

Elsevier

Access to resources Recommend Favorite

Anandamide transport inhibition by the vanilloid agonist olvanil

By Beltramo M. Piomelli D.

European Journal of Pharmacology, Vol. 364, Iss. 1, 1999-01 ,pp. : 75-78

Elsevier

Access to resources Recommend Favorite

Physiology and Pharmacology of the Vanilloid Receptor

Current Neuropharmacology, Vol. 4, Iss. 1, 2006-01 ,pp. : 1-15

Bentham Science Publishers

Access to resources Recommend Favorite

The anandamide transport inhibitor AM404 activates vanilloid receptors

By Zygmunt P.M. Chuang H.-h. Movahed P. Julius D. Hogestatt E.D.

European Journal of Pharmacology, Vol. 396, Iss. 1, 2000-05 ,pp. : 39-42

Elsevier

Access to resources Recommend Favorite

Inhibition of intestinal motility by anandamide, an endogenous cannabinoid

By Calignano A. La Rana G. Makriyannis A. Lin S.Y. Beltrano M. Piomelli D.

European Journal of Pharmacology, Vol. 340, Iss. 2, 1997-12 ,pp. : 7-8

Elsevier

Access to resources Recommend Favorite